COMETRIQ vs TASIGNA

Independent side-by-side comparison.

Rated against independent regulatory sources·Last updated August 17, 2026·How we rate

Possible drug interaction. COMETRIQ and TASIGNA are different prescription medicines. Combining or switching between them can cause interactions — talk to a pharmacist or prescriber before making changes. This page is not medical advice.

Attribute	COMETRIQ	TASIGNA
Rating	New	70/100
Pharmacy pays	—	—
Type	RX	RX
Active ingredient	CABOZANTINIB S-MALATE	NILOTINIB HYDROCHLORIDE
Manufacturer	Exelixis	Novartis
Dosage forms	Capsule, Kit	Capsule
Drug class	Kinase Inhibitor	Kinase Inhibitor
Boxed warning	None	Boxed warning
Treats	Renal Cell Carcinoma	Accelerated Phase Myeloid Leukemia, Chronic-Phase Myeloid Leukemia

cometriq tasigna

Rating

New

70/100

Pharmacy pays

—

Type

Active ingredient

CABOZANTINIB S-MALATE

NILOTINIB HYDROCHLORIDE

Manufacturer

Exelixis

Novartis

Dosage forms

Capsule, Kit

Capsule

Drug class

Kinase Inhibitor

Boxed warning

None

Boxed warning

Treats

Renal Cell Carcinoma

Accelerated Phase Myeloid Leukemia, Chronic-Phase Myeloid Leukemia

Frequently asked questions

What is the difference between Cometriq and Tasigna?

Cometriq contains Cabozantinib S-Malate, while Tasigna contains Nilotinib Hydrochloride — they have different active ingredients.

Ratings are based on FDA regulatory (recall-safety) data. This comparison is for general reference only — not medical advice. Always consult a licensed professional before choosing or switching a medication.